ID
27402
Descrizione
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977
Keywords
versioni (2)
- 13/11/17 13/11/17 -
- 26/11/17 26/11/17 -
Titolare del copyright
GlaxoSmithKline
Caricato su
13 novembre 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Contact #1 Year 1 GSK study Prostatic neoplasms NCT00883909
Contact #1 Year 1 GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM
Descrizione
Subject contact
Descrizione
If YES, record the date and type of contact.
Tipo di dati
text
Descrizione
Date of contact
Tipo di dati
date
Descrizione
Type of contact
Tipo di dati
text
Descrizione
If YES, ensure that all questions in the CONTACT #1 section have been completed. If NO, check primary reason interview was not completed and do not complete the questions in the section below ‘ CONTACT #1’.
Tipo di dati
text
Descrizione
If subject died, record details on the SERIOUS ADVERSE EVENT pages.
Tipo di dati
text
Descrizione
Other primary reason interview was not completed
Tipo di dati
text
Descrizione
CONTACT #1 - Since your participation in the REDUCE study (REDUCE 4 Year Contact):
Descrizione
If YES, Record the date of collection and local PSA results on the PSA RESULTS page.
Tipo di dati
text
Descrizione
If YES, • Enter the biopsy information and the local pathology results on the LOCAL PATHOLOGY RESULTS page. • Send biopsy sample to Central Pathology for Confirmatory Review only if the result is positive for prostate cancer. • If biopsy is positive for PCa enter any available new TNM stage information on the TNM STAGING HISTORY page.
Tipo di dati
text
Descrizione
If YES, • Enter surgical treatment for PCa on the PROSTATIC SURGICAL INTERVENTION page; and, • For radical prostatectomy, enter any local pathology information/ result on LOCAL PATHOLOGY RESULTS page. • For radical prostatectomies, send surgical sample to Central Pathology for confirmatory review, regardless of whether the result is positive or negative for prostate cancer. • For all prostate surgeries other than radical prostatectomies, send surgical sample to Central Pathology for confirmatory review only if the result is positive for prostate cancer. • Enter non-surgical treatment for PCa, on the NON-SURGICAL INTERVENTION FOR PROSTATE CANCER page. • Complete any further TNM staging information on the TNM STAGING HISTORY page.
Tipo di dati
text
Descrizione
If YES, • Enter the prostate surgery information on the PROSTATE SURGICAL INTERVENTION page; and, • Enter local pathology results for the surgery on the LOCAL PATHOLOGY RESULTS page. • Send surgical sample to Central Pathology for confirmatory review only if the result is positive for prostate cancer. • Complete any further TNM staging information on the TNM Staging History page.
Tipo di dati
text
Descrizione
medical problems or hospitalisations
Tipo di dati
text
Descrizione
If YES, Complete the SERIOUS ADVERSE EVENT pages and ensure they are faxed to GSK within 24 hours of becoming aware of the event.
Tipo di dati
text
Descrizione
Chronic concomitant medications include all prescription and nonprescription medication including vitamins, supplements and herbal remedies. Specifically include the use of dutasteride [Avodart ®] or finasteride [Proscar ® and Propecia ®]. If YES, • Enter information for all changes in chronic medications on the CONCOMITANT MEDICATIONS page(s).
Tipo di dati
text
Similar models
Contact #1 Year 1 GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM